by Xcellerant Ventures | Jul 27, 2024 | Portfolio Company News
Origionally posted on CRISPR QC’s website: https://crisprqc.com/wp-content/uploads/2024/08/20240806-CRISPR-Cleave-Case-Study-Layout.pdf Key Takeaways: CRISPR QC’s in vitro CRISPR-Cas cleavage assays can streamline CRISPR workflows by identifying optimal...
by Xcellerant Ventures | Jul 26, 2024 | Portfolio Company News
Origionally posted on CRISPR QC’s website: https://crisprqc.com/wp-content/uploads/2024/08/20240806-CRISPR-RNP-Case-Study-Layout.pdf Key Takeaways: A critical gap exists in the CRISPR workflow: the lack of an in vitro QC step. The CRISPR Analytics...
by Xcellerant Ventures | Jul 25, 2024 | Portfolio Company News
Origionally posted on CRISPR QC’s website: https://crisprqc.com/wp-content/uploads/2024/08/20240806-CRISPR-DNA-Case-Study-Layout.pdf Key Takeaways: The CRISPR Analytics Platform is an in vitro tool for measuring CRISPR editing efficiency, as well as, RNP...
by Tiffany Youtchoko | Jul 17, 2024 | Portfolio Company News
Origionally posted on TTI’s website: https://tti.care/2024-asco-breakthrough-abstract-award-winner/ Recognized by Conquer Cancer®, the ASCO® Foundation, and the 2024 ASCO® Breakthrough Program Committee, Prestigious Award Recognizes Top Scoring Study...
by Xcellerant Ventures | Jul 9, 2024 | Portfolio Company News
Origionally posted on EIN Presswire: https://www.einpresswire.com/article/710284206/lenoss-medical-oversubscribes-4-million-series-a-financing Dom Messerli isn’t an M.D., but based on his success in the medical device field so far, he knows how to fix a spine. He’s a...
by Xcellerant Ventures | Jul 9, 2024 | Portfolio Company News
Origionally posted on AdviNOW Medical’s website: https://advinow.com/advinow-featured-in-gartner-hype-cycle-for-digital-clinical-encounters-for-fourth-consecutive-year/ We are thrilled to announce that AdviNOW has been recognized in the Gartner Hype...
